Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Rank in Stocks #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Share Price
$25.61
Last synced: 2025-10-10
Market Cap
$1.37B
Change (1 day)
0.20%
Change (1 year)
1.55%
Country
US
Trade Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Category

Dividend yield history for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Harrow Health, Inc. 8.625% Senior Notes due 2026 (stock symbol: HROWL) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors